Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Livingstone

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
BMC Cancer|April 18, 2015
A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancerAbdel Nasser Hosein, Julie Livingstone, Marguerite Buchanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failureLaurent Sansregret, Charles Vadnais, Julie Livingstone, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
moPepGen: Rapid and Comprehensive Identification of Non-canonical PeptidesChenghao Zhu, Lydia Y Liu, Annie Ha, et al.
European Urology Open Science|August 2, 2021
Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal DiseaseSimon R Walker, Ramy Abdelsalam, Sunita Ghosh, et al.
Nature Biotechnology|June 16, 2025
Identification of non-canonical peptides with moPepGenChenghao Zhu, Lydia Y Liu, Annie Ha, et al.
Cancers|June 2, 2021
Copy Number Profiles of Prostate Cancer in Men of Middle Eastern AncestryAlia Albawardi, Julie Livingstone, Saeeda Almarzooqi, et al.
Nature Communications|October 30, 2021
Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapseMichael Fraser, Julie Livingstone, Jeffrey L Wrana, et al.
European Urology Open Science|June 27, 2025
Corrigendum to "Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease" [Eur. Urol. Open Sci. 29 (2021) 93-101]Simon R Walker, Ramy A Abdelsalam, Sunita Ghosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 19, 2022
Methylation Subtypes of Primary Prostate Cancer Predict Poor PrognosisXiaoyu Wang, Kristina M Jordahl, Chenghao Zhu, et al.
European Urology Oncology|November 9, 2025
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical TrialRaag Agrawal, Adam B Weiner, Julie Livingstone, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
BMC Cancer|April 18, 2015
A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancerAbdel Nasser Hosein, Julie Livingstone, Marguerite Buchanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failureLaurent Sansregret, Charles Vadnais, Julie Livingstone, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
moPepGen: Rapid and Comprehensive Identification of Non-canonical PeptidesChenghao Zhu, Lydia Y Liu, Annie Ha, et al.
European Urology Open Science|August 2, 2021
Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal DiseaseSimon R Walker, Ramy Abdelsalam, Sunita Ghosh, et al.
Nature Biotechnology|June 16, 2025
Identification of non-canonical peptides with moPepGenChenghao Zhu, Lydia Y Liu, Annie Ha, et al.
Cancers|June 2, 2021
Copy Number Profiles of Prostate Cancer in Men of Middle Eastern AncestryAlia Albawardi, Julie Livingstone, Saeeda Almarzooqi, et al.
Nature Communications|October 30, 2021
Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapseMichael Fraser, Julie Livingstone, Jeffrey L Wrana, et al.
European Urology Open Science|June 27, 2025
Corrigendum to "Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease" [Eur. Urol. Open Sci. 29 (2021) 93-101]Simon R Walker, Ramy A Abdelsalam, Sunita Ghosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 19, 2022
Methylation Subtypes of Primary Prostate Cancer Predict Poor PrognosisXiaoyu Wang, Kristina M Jordahl, Chenghao Zhu, et al.
European Urology Oncology|November 9, 2025
Neoadjuvant Antiandrogen Therapy With or Without MEK or SRC Inhibition for Unfavorable-risk Prostate Cancer: A Phase 2 Randomized Clinical TrialRaag Agrawal, Adam B Weiner, Julie Livingstone, et al.
Pageof 5